Sign In
Buy GBT
$68.49
+0 (+0%)
At Close: Jan 27, 2023
Incyte (INCY) Receives a Buy from Nomura
11:23am, Wednesday, 08'th Apr 2020
In a report issued on April 6,
Christopher Marai
from Nomura maintained a
Buy
rating on Incyte (
INCY
–
Research Report
), with a price target of
$116.00
. The company’s shares closed last Tuesday
Analysts Conflicted on These Healthcare Names: Biogen (BIIB), Alnylam Pharma (ALNY) and Agios Pharma (AGIO)
11:16am, Wednesday, 08'th Apr 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biogen (BIIB), Alnylam Pharma (ALNY) and Agios Pharma
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (BNGO) and PTC Therapeutics (PTCT)
10:14am, Wednesday, 08'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNano Genomics (BNGO) and PTC Therapeutics (PTCT) with
Analysts Offer Insights on Healthcare Companies: BioNano Genomics (NASDAQ: BNGO) and PTC Therapeutics (NASDAQ: PTCT)
10:14am, Wednesday, 08'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on BioNano Genomics
